UNION KOREA PHARM CO (080720) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, UNION KOREA PHARM CO (080720) reported revenue of 36.4 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202536.4 billion KRW-17.2 billion KRW-30.8 billion KRW[source]
202451.3 billion KRW-13.5 billion KRW-20.9 billion KRW[source]
202363.2 billion KRW-5.2 billion KRW-18.2 billion KRW[source]
202261.3 billion KRW1.3 billion KRW-932 million KRW[source]
202148.3 billion KRW-10.6 billion KRW-11.1 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202546.0 billion KRW68.6 billion KRW-22.6 billion KRW[source]
202474.9 billion KRW66.5 billion KRW8.4 billion KRW[source]
202394.3 billion KRW64.0 billion KRW30.3 billion KRW[source]
2022114.9 billion KRW63.8 billion KRW51.2 billion KRW[source]
2021119.6 billion KRW65.3 billion KRW54.3 billion KRW[source]

Cash Flow

YearOperatingInvestingFinancingSource
2025-1.1 billion KRW1.1 billion KRW-1.2 billion KRW[source]
2024415 million KRW-821 million KRW-1.9 billion KRW[source]
20231.4 billion KRW-2.1 billion KRW1.3 billion KRW[source]
2022-5.1 billion KRW-3.5 billion KRW-6.0 billion KRW[source]
20211.9 billion KRW-8.1 billion KRW25.2 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice